NOVARTIS AG 13D and 13G filings for MorphoSys AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 4:01 pm Purchase |
2024-10-15 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 37,716,423 100.000% |
2,108,003 (+5.92%) |
Filing |
| 2024-08-15 4:30 pm Purchase |
2024-08-13 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 35,608,420 94.550% |
1,270,611 (+3.70%) |
Filing |
| 2024-06-21 4:30 pm Unchanged |
2024-06-19 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 34,337,809 91.170% |
0 (Unchanged) |
Filing |
| 2024-06-17 4:30 pm Purchase |
2024-06-16 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 34,337,809 91.170% |
641,331 (+1.90%) |
Filing |
| 2024-06-10 4:30 pm Purchase |
2024-06-06 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 33,696,478 89.470% |
3,725,565 (+12.43%) |
Filing |
| 2024-05-28 4:30 pm Purchase |
2024-05-23 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 29,970,913 79.580% |
25,610,813 (+587.39%) |
Filing |
| 2024-04-18 2:33 pm Purchase |
2024-04-12 | 13D | MorphoSys AG MOR |
NOVARTIS AG | 4,360,100 11.560% |
4,360,100 (New Position) |
Filing |